121 related articles for article (PubMed ID: 21463909)
1. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture.
Vestergaard P; Steinberg TH; Schwarz P; Jørgensen NR
Int J Cardiol; 2012 Sep; 160(1):36-40. PubMed ID: 21463909
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study.
Jørgensen NR; Grove EL; Schwarz P; Vestergaard P
J Intern Med; 2012 Oct; 272(4):385-93. PubMed ID: 22372976
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
5. The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population.
Isordia-Salas I; Olalde-Román MJ; Santiago-Germán D; de la Peña NC; Valencia-Sánchez JS
Thromb Res; 2012 Sep; 130(3):e67-72. PubMed ID: 22819265
[TBL] [Abstract][Full Text] [Related]
6. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel: the data, the experience, and the controversies.
Sadanandan S; Singh IM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):361-74. PubMed ID: 23057989
[TBL] [Abstract][Full Text] [Related]
8. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Christiansen CB; Pallisgaard J; Gerds TA; Olesen JB; Jørgensen ME; Numé AK; Carlson N; Kristensen SL; Gislason G; Torp-Pedersen C
BMC Neurol; 2015 Nov; 15():225. PubMed ID: 26525411
[TBL] [Abstract][Full Text] [Related]
10. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
[TBL] [Abstract][Full Text] [Related]
11. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
Bernlochner I; Byrne RA; Kastrati A; Sibbing D
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
[TBL] [Abstract][Full Text] [Related]
12. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
[TBL] [Abstract][Full Text] [Related]
13. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
14. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome.
Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A
Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493
[TBL] [Abstract][Full Text] [Related]
16. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
Breet NJ; van Werkum JW; Bouman HJ; Kelder JC; Harmsze AM; Hackeng CM; ten Berg JM
Heart; 2011 Jun; 97(12):983-90. PubMed ID: 21478385
[TBL] [Abstract][Full Text] [Related]
17. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Busse O; Diener HC; Grond M
Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
[No Abstract] [Full Text] [Related]
18. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
19. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
20. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]